| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.097 | 0.07 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.51 | 0.07 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.31 | 0.08 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.25 | 0.08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.093 | 0.08 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |